Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Awad

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Impaired c-Met Receptor Degradation Mediated by MET Exon 14 Mutations in Non-Small-Cell Lung CancerMark M Awad
JAMA Oncology|December 15, 2022
Atezolizumab Plus Bevacizumab in TMB-High Non-Small Cell Lung Cancers-The Hunt for Predictive Biomarkers to Optimize Treatment SelectionBiagio Ricciuti, Mark M Awad
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 27, 2022
Reply to Kus and AktasBiagio Ricciuti, Mark M Awad
Cancer Journal (Sudbury, Mass.)|December 10, 2020
What Is the Standard First-Line Treatment for Advanced Non-Small Cell Lung Cancer?Biagio Ricciuti, Mark M Awad
JTO Clinical and Research Reports|September 30, 2021
Reply to Cortellini ABiagio Ricciuti, Mark M Awad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Durable Responses With PD-1 Inhibition in Lung and Kidney Cancer and the Ongoing Search for Predictive BiomarkersMark M Awad, Peter S Hammerman
Clinical Advances in Hematology & Oncology : H&O|October 17, 2014
ALK inhibitors in non-small cell lung cancer: crizotinib and beyondMark M Awad, Alice T Shaw
The Lancet. Respiratory Medicine|March 23, 2020
Immunotherapy in lung cancer: effective for patients with poor performance status?Joao V Alessi, Mark M Awad
Expert Review of Clinical Pharmacology|December 5, 2014
Dabrafenib in combination with trametinib for the treatment of metastatic melanomaMark M Awad, Ryan J Sullivan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 21, 2023
Letter to the Editor: Reply to Kus and AktasJoao V Alessi, Mark M Awad
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Impaired c-Met Receptor Degradation Mediated by MET Exon 14 Mutations in Non-Small-Cell Lung CancerMark M Awad
JAMA Oncology|December 15, 2022
Atezolizumab Plus Bevacizumab in TMB-High Non-Small Cell Lung Cancers-The Hunt for Predictive Biomarkers to Optimize Treatment SelectionBiagio Ricciuti, Mark M Awad
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 27, 2022
Reply to Kus and AktasBiagio Ricciuti, Mark M Awad
Cancer Journal (Sudbury, Mass.)|December 10, 2020
What Is the Standard First-Line Treatment for Advanced Non-Small Cell Lung Cancer?Biagio Ricciuti, Mark M Awad
JTO Clinical and Research Reports|September 30, 2021
Reply to Cortellini ABiagio Ricciuti, Mark M Awad
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Durable Responses With PD-1 Inhibition in Lung and Kidney Cancer and the Ongoing Search for Predictive BiomarkersMark M Awad, Peter S Hammerman
Clinical Advances in Hematology & Oncology : H&O|October 17, 2014
ALK inhibitors in non-small cell lung cancer: crizotinib and beyondMark M Awad, Alice T Shaw
The Lancet. Respiratory Medicine|March 23, 2020
Immunotherapy in lung cancer: effective for patients with poor performance status?Joao V Alessi, Mark M Awad
Expert Review of Clinical Pharmacology|December 5, 2014
Dabrafenib in combination with trametinib for the treatment of metastatic melanomaMark M Awad, Ryan J Sullivan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 21, 2023
Letter to the Editor: Reply to Kus and AktasJoao V Alessi, Mark M Awad
Pageof 21